Corporate Members

Company Name¡GEli Lilly and Company  (Taiwan), Inc.
Address¡G
11/F, 365, Fu Hsing N.Road, Taipei, 105, Taiwan,ROC
Telephone¡G(02)2715-2950
Fax¡G(02)2716-3314
E-mail ¡G
Taiwan@lilly.com
Website¡Gwww.lilly.com.tw

General Manager¡GMelt van der Spuy
Established in¡GMarch 1966  



¡@
Lilly, founded in 1876, is a leading innovation-driven and research-based pharmaceutical corporation dedicated to excellence in the life sciences. Lilly is developing a growing portfolio of pharmaceutical products that are among the best in their class, and often first in their class, by applying the latest research from its own worldwide laboratories, by collaborating with eminent scientific organizations, and by making use of the most up-to-date technological tools. 

¡@Lilly has more than 43,000 employees worldwide and markets its medicines in 146 countries. Lilly has major research and development facilities in eight countries and conducts clinical trials in more than 60 countries, including Taiwan. In 2002, R&D expenditures were 19% of its total sales.

¡@Lilly began operations in Taiwan in 1966. Since then, the Taiwan affiliate has steadily expanded its scale of operations. Besides marketing high-quality pharmaceutical products, the company is investing substantial sums of money in conducting global and local clinical research. In the last decade, Lilly Taiwan has introduced important new drugs for the treatment of cancer, schizophrenia, osteoporosis, diabetes, etc., and provided medical information services which have helped people live healthier lives and improve their quality of life. The company will continue to make investments in clinical research in Taiwan, in order to provide people more effective and safe clinical therapies.

¡@Lilly Taiwan will focus on the development of closer links to government organizations, medical associations, and advocacy groups. Through these links, Lilly hopes to make positive contributions to the advancement of research and technology in Taiwan's life science industry. 

Lilly Values

¡@The following long-established core values guide every aspect of the company in the implementation of its strategies and objectives:

¡@Respect for people, which includes concern for the interests of all people worldwide who touch or are touched by the company: customers, employees, shareholders, partners, suppliers, and communities; Integrity that embraces the very highest standards of honesty, ethical behavior, and exemplary moral character; Excellence that is reflected in the continuous search for new ways to improve the performance of the company, and lead it to become the best in the industry. 

¡@Therapeutic Areas: Targeting Unmet Medical Needs

¡@The company's mission includes finding answers for some of the world's most urgent medical needs. Lilly focuses its internal research efforts primarily on six core therapeutic areas: neuroscience; endocrine disorders; cancer; infectious diseases; cardiovascular diseases; and gene regulation, bone, and inflammation. Lilly also continues to pursue innovative science and new opportunities beyond these targeted disease categories. Lilly's pipeline is one of the strongest in the industry, and has the potential to address many of the serious unmet medical needs of people around the world.

Recognition

¡@One of the 100 Best Companies to Work For (four consecutive years) - Fortune magazine 
¡@Top pharmaceutical company and 63rd among the 500 most innovative users of technology ¡@-Information Week magazine 
¡@Ranked tenth in Best Company Benefits - Money magazine 
¡@One of the 100 Best Corporate Citizens, ranked 66th - Business Ethics magazine 
¡@One of the top four Best Companies for Scientists - Science magazine 

Major Products

¡@Zyprexa for schizophrenia and acute mania associated with bipolar disorder 
¡@Prozac for depression 
¡@Gemzar for pancreatic and non-small-cell lung cancer 
¡@Evista for the prevention and treatment of postmenopausal osteoporosis 
¡@Humulin and Humalog for diabetes 
¡@Antibiotic products: Vancocin¡BKeflor¡BKeflex Kefadim 
¡@
¡@In the coming years, many new products will be launched, for example, Forteo for osteoporosis, Cialis for male erectile dysfunction, Xigris for severe sepsis, Strattera for attention-deficit hyperactivity disorder, Cymbalta for depression, Yentreve for stress urinary incontinence, and Alimta for mesothelioma.


¡öHOME | ¡ôTOP